Dr. Chris Beyrer is the Desmond M. Tutu Professor in Public Health and Human Rights at the Johns Hopkins Bloomberg School of Public Health. An infectious diseases epidemiologist, he currently serves as Senior Scientific Liaison to the COVID-19 Vaccine Prevention Network, the Co-VPN, for Community Engagement. He is a Professor […]
Read More
Sept 10 (Reuters) – Top U.S. health officials believe that Pfizer Inc’s (PFE.N) COVID-19 vaccine could be authorized for children aged 5-11 years old by the end of October, two sources familiar with the situation said on Friday. The timeline is based on the expectation that Pfizer, which developed the shot with […]
Read More
Pfizer, Moderna mRNA vaccines are effective even without post-shot symptoms or prior infection, Johns Hopkins study finds When the two messenger RNA vaccines for COVID-19 first became readily available, many people were talking about side effects—everything from headaches to chills to feeling exhausted for a couple days. Yet plenty of […]
Read More
An independent expert panel within the Centers for Disease Control and Prevention (CDC) has studied the potential benefits and risks of the Pfizer-BioNTech COVID-19 vaccine and voted unanimously to recommend the shots for all Americans ages 16 and older. All 14 members of the Advisory Committee on Immunization Practices (ACIP) […]
Read More
Side effects from the Pfizer/BioNTech vaccine in children aged between 12 and 15 and considered vulnerable to COVID-19 infection were mostly mild or moderate, a small study has suggested. Researchers in Bristol looked at 27 children whose parents recorded any side effects after the jab. Adverse reactions were either mild […]
Read More
Moderna Inc.’s Covid vaccine generated more than double the antibodies of a similar shot made by Pfizer Inc. and BioNTech SE in research that compared immune responses evoked by the two inoculations. The study is one of the first to compare levels of antibodies produced by the two vaccines, which are thought to be […]
Read More
Although the FDA granted full approval for the Pfizer COVID-19 vaccine for ages 16 and up on Monday, officials have added a note of caution to parents and doctors — the shot isn’t yet intended for use in kids. In particular, the first fully approved COVID-19 vaccine shouldn’t be given to ages […]
Read More
The Food and Drug Administration gave full approval to the Pfizer COVID-19 vaccine on Monday, Aug. 23, making it the first COVID-19 vaccine to receive such approval. The Pfizer vaccine was previously available under an FDA emergency use authorization. This emergency use authorization followed rigorous testing that included thousands of […]
Read More
Pfizer’s two-dose Covid-19 vaccine has received full approval from the US Food and Drug Administration (FDA) – the first jab to be licensed in the nation. The vaccine had initially been given emergency use authorisation. Its two jabs, three weeks apart, are now fully approved for those aged 16 and […]
Read More
De acuerdo con medios locales, Israel se prepara para aplicar una tercera dosis de la vacuna de Pfizer a personas mayores de 60 años. Pues para reforzar la vacunación entre personas mayores de 60 años, Israel decidió que habrá una tercera dosis de la vacuna contra COVID-19 de Pfizer y BioNTech. Al menos […]
Read More